Lidocaine HCI Injection, USP, by Hospira: Recall - Visible Particulates
Risk of local inflammation, and/or mechanical disruption of tissue or immune response to the particulate, and/or a delay in therapy.
Risk of local inflammation, and/or mechanical disruption of tissue or immune response to the particulate, and/or a delay in therapy.
80.211.154.110